↓ Skip to main content

Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus

Overview of attention for article published in Frontiers in immunology, September 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
4 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus
Published in
Frontiers in immunology, September 2020
DOI 10.3389/fimmu.2020.02029
Pubmed ID
Authors

Bárbara Soria-Juan, Natalia Escacena, Vivian Capilla-González, Yolanda Aguilera, Lucía Llanos, Juan R. Tejedo, Francisco J. Bedoya, Verónica Juan, Antonio De la Cuesta, Rafael Ruiz-Salmerón, Enrique Andreu, Lukas Grochowicz, Felipe Prósper, Fermín Sánchez-Guijo, Francisco S. Lozano, Manuel Miralles, Lourdes Del Río-Solá, Gregorio Castellanos, José M. Moraleda, Robert Sackstein, Mariano García-Arranz, Damián García-Olmo, Franz Martín, Abdelkrim Hmadcha, Bernat Soria, the Collaborative Working Group “Noma Project Team”

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 1 25%
Unknown 3 75%
Readers by discipline Count As %
Medicine and Dentistry 1 25%
Unknown 3 75%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 September 2020.
All research outputs
#17,297,846
of 25,387,668 outputs
Outputs from Frontiers in immunology
#20,310
of 31,541 outputs
Outputs of similar age
#271,403
of 424,802 outputs
Outputs of similar age from Frontiers in immunology
#594
of 880 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,541 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 424,802 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 880 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.